Brief: UK's MHRA Approves Dawnzera For Treatment Of Familial Chylomicronemia Syndrome
Table: Otsuka -Q1 group results
Table: Otsuka -2025 group results
Table: Otsuka -2025 parent results
US FDA approves Otsuka's kidney disease drug
Table: Otsuka - 9-MTH group results
Brief: Fangzhou Launches “Xingshi” LLM, Says in Innovent, Otsuka Tie-up
Table: Otsuka - 6-MTH group results
Table: Otsuka -Q1 group results
Table: Otsuka -2024 group results
Table: Otsuka -2024 parent results
Table: Otsuka - 9-MTH group results
Advisory: Alert wrongly tagged to Otsuka Corp withdrawn
Table: Otsuka -Q1 group results
Brief: Otsuka Corp - To Conduct 2-For-1 Share Split For Shareholders As Of Nar 31
Table: Otsuka -2023 parent results
Table: Otsuka -2023 group results
Table: Otsuka - 9-MTH group results
Table: Otsuka - 6-MTH group results